2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC). (September 2015) - Lorente, D.; Ravi, P.; Mehra, N.; Gillman, A.; Omlin, A.; Pezaro, C.; Miranda, M.; Mateo, J.; Rescigno, P.; Kolinsky, M.; Porta, N.; Jayaram, A.; et al.